04 Oct 2017
HistoIndex Receives Frost & Sullivan 2017 Asia-Pacific Best...
Date: 04 Oct 2017
Histoindex Pte. Ltd. has been presented with the 2017 Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Diagnostics New Product Innovation Award by Frost & Sullivan. The award is a testament of the achievements by HistoIndex and the impact of its proprietary technologies such as Genesis®200 on aiding clinical diagnosis and the development of NASH therapeutics.
Read More
13 Jan 2016
HistoIndex Signs RMB15 million Co-investment Deal with JoinS...
Date: 13 Jan 2016
China-based Qingdao Yaozhu has entered into a joint venture agreement to co-invest with Singapore-headquartered medtech company, HistoIndex®.
Read More